EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CCL3 is produced by aged neutrophils across cancers and promotes tumor growth

Evangelia Bolli, Pratyaksha Wirapati, Mehdi Hicham, Yuxuan Xie, Marie Siwicki, Florent Duval, Anne-Gaëlle Goubet, Máté Kiss, Béatrice Zitti, Thomas Zwahlen, Sheri Mcdowell, Ruben Bill und 19 weitere

Cancer Cell · 2026-03 · 44 (3) · 624-640.e12

DOI: 10.1016/j.ccell.2026.01.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2026-03. Verfasst von Evangelia Bolli und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; AGORA Cancer Research Center, and Swiss Cance…. Hauptthemen laut MEDLINE: Neutrophils, Neoplasms, Chemokine CCL3. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDCR NIH HHS, American Society of Hematology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-associated neutrophils (TANs) are abundant across cancers, yet their phenotypic diversity and functional states remain poorly defined. Here, we introduce a cell-type probability classifier that recovers low-transcript neutrophils from scRNAseq datasets, enabling pan-cancer analyses of TAN heterogeneity. Across >190 human and murine tumors, we identify a conserved differentiation trajectory that culminates in a terminal CCL3 hi state. This state exhibits pro-tumor transcriptional programs, including those involved in hypoxic adaptation and senescence. Consistently, CCL3 hi TANs are enriched in hypoxic tumor niches in both humans and mice. Through mechanistic perturbations of neutrophil-derived CCL3 in mice, we show that it sustains TAN survival in hypoxic tumor regions via CCR1-dependent signaling. These findings establish CCL3 as a conserved marker and functional driver of pro-tumor neutrophils in growing tumors, and provide a scalable framework for dissecting neutrophil biology across cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsNeoplasmsChemokine CCL3AnimalsHumansMiceReceptors, CCR1Tumor MicroenvironmentSignal TransductionCellular SenescenceCell DifferentiationGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

CCL3-CCR1 signalingCRISPR perturbationhypoxianeutrophil agingneutrophil differentiationneutrophil heterogeneitypan-cancer analysissingle-cell RNA sequencingtumor microenvironmenttumor-promoting neutrophils

Substanzen

Receptors, CCR1Chemokine CCL3Ccl3 protein, mouseCCR1 protein, human

Autor:innen und Institutionen

  • Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; AGORA Cancer Research Center, and Swiss Cancer Center Leman, Lausanne, Switzerland; Translational Research Center i…
  • Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada.
  • Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; AGORA Cancer Research Center, and Swiss Cancer Center Leman, Lausanne, Switzerland; Department of Medical Oncology,…
  • Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • SciLifeLab, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.

Förderung

  • NCI NIH HHS
  • NIDCR NIH HHS
  • American Society of Hematology
  • Horizon 2020 Framework Programme
  • Human Frontier Science Program
  • Swiss National Science Foundation
  • National Institutes of Health
  • Belgian American Educational Foundation Inc

Zitieren

APA

Bolli, E., Wirapati, P., Hicham, M., Xie, Y., Siwicki, M., Duval, F., Goubet, A. G., Kiss, M., Zitti, B., Zwahlen, T., Mcdowell, S., Bill, R., Angerani, S., Engblom, C., Anderson, S., Jiang, A., Hartley, O., Sykes, D. B., Jankovic, M., …, & Pittet, M. J. (2026). CCL3 is produced by aged neutrophils across cancers and promotes tumor growth. Cancer Cell, 44(3), 624-640.e12. https://doi.org/10.1016/j.ccell.2026.01.006

Vancouver

Bolli E, Wirapati P, Hicham M, Xie Y, Siwicki M, Duval F, et al. CCL3 is produced by aged neutrophils across cancers and promotes tumor growth. Cancer Cell. 2026;44(3):624-640.e12. doi:10.1016/j.ccell.2026.01.006

BibTeX
@article{Bolli2026,
  author = {Bolli, Evangelia and Wirapati, Pratyaksha and Hicham, Mehdi and Xie, Yuxuan and Siwicki, Marie and Duval, Florent and Goubet, Anne-Gaëlle and Kiss, Máté and Zitti, Béatrice and Zwahlen, Thomas and Mcdowell, Sheri and Bill, Ruben and Angerani, Simona and Engblom, Camilla and Anderson, Seth and Jiang, Aiping and Hartley, Oliver and Sykes, David B and Jankovic, Maja and Fournier, Nadine and Gunzer, Matthias and Tarussio, David and Tissot, Stéphanie and Sadow, Peter M and Faquin, William C and Sade-Feldman, Moshe and Weissleder, Ralph and Pai, Sara and Mercier, François and Manguso, Robert and Pittet, Mikaël J},
  title = {CCL3 is produced by aged neutrophils across cancers and promotes tumor growth},
  journal = {Cancer Cell},
  year = {2026},
  volume = {44},
  number = {3},
  pages = {624--640.e12},
  doi = {10.1016/j.ccell.2026.01.006}
}
Kostenlos starten →